TreeWAS – Variant ID: rs4625043

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N30 Cystitis	0.851	0.149	0.000
N30.2 Other chronic cystitis	0.845	0.155	0.000
N30.9 Cystitis, unspecified	0.830	0.170	0.000
N30.3 Trigonitis	0.817	0.183	0.000
N30.8 Other cystitis	0.809	0.191	0.000
N30.0 Acute cystitis	0.783	0.217	0.000
N30.1 Interstitial cystitis (chronic)	0.594	0.406	0.000
N30.4 Irradiation cystitis	0.561	0.439	0.000
N89.8 Other specified noninflammatory disorders of vagina	0.000	0.783	0.217
N89 Other noninflammatory disorders of vagina	0.000	0.837	0.163
N89.5 Stricture and atresia of vagina	0.000	0.845	0.155
N89.9 Noninflammatory disorder of vagina, unspecified	0.000	0.876	0.124
N89.1 Moderate vaginal dysplasia	0.000	0.876	0.123
N89.7 Haematocolpos	0.000	0.883	0.117
N89.2 Severe vaginal dysplasia, not elsewhere classified	0.000	0.883	0.117
N89.4 Leukoplakia of vagina	0.000	0.886	0.114
N89.0 Mild vaginal dysplasia	0.000	0.887	0.113
N89.3 Dysplasia of vagina, unspecified	0.000	0.889	0.111
N89.6 Tight hymenal ring	0.000	0.899	0.101
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.021	0.979	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.020	0.980	0.000
T40.4 Other synthetic narcotics	0.020	0.980	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.019	0.981	0.000
I12.0 Hypertensive renal disease with renal failure	0.019	0.981	0.000
N30-N39 Other diseases of urinary system	0.019	0.981	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.019	0.981	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.018	0.982	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.018	0.982	0.000
B37.8 Candidiasis of other sites	0.018	0.982	0.000
T31.0 Burns involving less than 10% of body surface	0.000	0.983	0.017
T43.2 Other and unspecified antidepressants	0.016	0.984	0.000
T40.6 Other and unspecified narcotics	0.016	0.984	0.000
R47.8 Other and unspecified speech disturbances	0.000	0.984	0.016
T43.5 Other and unspecified antipsychotics and neuroleptics	0.016	0.984	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.016	0.984	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.016	0.984	0.000
T36 Poisoning by systemic antibiotics	0.016	0.984	0.000
I12 Hypertensive renal disease	0.016	0.984	0.000
I12.9 Hypertensive renal disease without renal failure	0.016	0.984	0.000
N36.8 Other specified disorders of urethra	0.015	0.985	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.015	0.985	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.015	0.985	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.015	0.985	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.015	0.985	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.015	0.985	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.015	0.985	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.015	0.985	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.015	0.985	0.000
T44.0 Anticholinesterase agents	0.015	0.985	0.000
T40.3 Methadone	0.015	0.985	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.014	0.985	0.000
N36 Other disorders of urethra	0.014	0.986	0.000
T43.6 Psychostimulants with abuse potential	0.014	0.986	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.014	0.986	0.000
T40.8 Lysergide [LSD]	0.014	0.986	0.000
T40.7 Cannabis (derivatives)	0.014	0.986	0.000
T40.0 Opium	0.014	0.986	0.000
T36.0 Penicillins	0.014	0.986	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.014	0.986	0.000
N37 Urethral disorders in diseases classified elsewhere	0.014	0.986	0.000
N33 Bladder disorders in diseases classified elsewhere	0.014	0.986	0.000
T40.2 Other opioids	0.014	0.986	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.014	0.986	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.014	0.986	0.000
T40.1 Heroin	0.013	0.987	0.000
T40.5 Cocaine	0.013	0.987	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.013	0.987	0.000
T38.1 Thyroid hormones and substitutes	0.013	0.987	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.013	0.987	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.013	0.987	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.013	0.987	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.013	0.987	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.012	0.988	0.000
T38.5 Other oestrogens and progestogens	0.012	0.988	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.012	0.988	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.012	0.988	0.000
M25.51 Pain in joint (Shoulder region)	0.000	0.988	0.012
N34 Urethritis and urethral syndrome	0.012	0.988	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.012	0.988	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.012	0.988	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.012	0.988	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.012	0.988	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.012	0.988	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.012	0.988	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.012	0.988	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.012	0.988	0.000
T38.9 Other and unspecified hormone antagonists	0.012	0.988	0.000
T38.7 Androgens and anabolic congeners	0.012	0.988	0.000
T38.4 Oral contraceptives	0.012	0.988	0.000
T38.2 Antithyroid drugs	0.012	0.988	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.011	0.988	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.011	0.988	0.000
T46.7 Peripheral vasodilators	0.011	0.988	0.000
T36.9 Systemic antibiotic, unspecified	0.011	0.989	0.000
T36.7 Antifungal antibiotics, systemically used	0.011	0.989	0.000
T36.6 Rifamycins	0.011	0.989	0.000
T36.5 Aminoglycosides	0.011	0.989	0.000
T36.2 Chloramphenicol group	0.011	0.989	0.000
T43.9 Psychotropic drug, unspecified	0.011	0.989	0.000
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.011	0.989	0.000
T36.8 Other systemic antibiotics	0.011	0.989	0.000
T47.6 Antidiarrhoeal drugs	0.011	0.989	0.000
T36.4 Tetracyclines	0.011	0.989	0.000
T38.0 Glucocorticoids and synthetic analogues	0.011	0.989	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.011	0.989	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.011	0.989	0.000
T48.4 Expectorants	0.011	0.989	0.000
T48.3 Antitussives	0.011	0.989	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.011	0.989	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.011	0.989	0.000
T48.0 Oxytocic drugs	0.011	0.989	0.000
T36.3 Macrolides	0.010	0.989	0.000
T47.4 Other laxatives	0.010	0.990	0.000
T47.2 Stimulant laxatives	0.010	0.990	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.010	0.990	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.010	0.990	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.010	0.990	0.000
T47.7 Emetics	0.010	0.990	0.000
T47.5 Digestants	0.010	0.990	0.000
T47.3 Saline and osmotic laxatives	0.010	0.990	0.000
T48.5 Anti-common-cold drugs	0.010	0.990	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.010	0.990	0.000
T50.8 Diagnostic agents	0.010	0.990	0.000
N33.8 Bladder disorders in other diseases classified elsewhere	0.010	0.990	0.000
N33.0 Tuberculous cystitis	0.010	0.990	0.000
N37.8 Other urethral disorders in diseases classified elsewhere	0.010	0.990	0.000
N37.0 Urethritis in diseases classified elsewhere	0.010	0.990	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.010	0.990	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.010	0.990	0.000
T49.9 Topical agent, unspecified	0.010	0.990	0.000
T49.8 Other topical agents	0.010	0.990	0.000
T49.7 Dental drugs, topically applied	0.010	0.990	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.010	0.990	0.000
T49.5 Ophthalmological drugs and preparations	0.010	0.990	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.010	0.990	0.000
T49.3 Emollients, demulcents and protectants	0.010	0.990	0.000
T49.2 Local astringents and local detergents	0.010	0.990	0.000
T49.1 Antipruritics	0.010	0.990	0.000
T41.5 Therapeutic gases	0.010	0.990	0.000
T41.4 Anaesthetic, unspecified	0.010	0.990	0.000
T41.3 Local anaesthetics	0.010	0.990	0.000
T41.1 Intravenous anaesthetics	0.010	0.990	0.000
T41.0 Inhaled anaesthetics	0.010	0.990	0.000
T41.2 Other and unspecified general anaesthetics	0.010	0.990	0.000
T46.1 Calcium-channel blockers	0.010	0.990	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.010	0.990	0.000
T50.4 Drugs affecting uric acid metabolism	0.010	0.990	0.000
N34.0 Urethral abscess	0.010	0.990	0.000
T47.0 Histamine H(2)-receptor antagonists	0.010	0.990	0.000
T50.7 Analeptics and opioid receptor antagonists	0.010	0.990	0.000
T50.5 Appetite depressants	0.010	0.990	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.010	0.990	0.000
T50.0 Mineralocorticoids and their antagonists	0.010	0.990	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.009	0.990	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.009	0.990	0.000
T37.5 Antiviral drugs	0.009	0.990	0.000
T37.4 Anthelminthics	0.009	0.990	0.000
T37.3 Other antiprotozoal drugs	0.009	0.990	0.000
T37.1 Antimycobacterial drugs	0.009	0.990	0.000
T37.0 Sulphonamides	0.009	0.990	0.000
N36.0 Urethral fistula	0.009	0.990	0.000
N36.1 Urethral diverticulum	0.009	0.990	0.000
T50.1 Loop [high-ceiling] diuretics	0.009	0.991	0.000
N34.3 Urethral syndrome, unspecified	0.009	0.991	0.000
B37 Candidiasis	0.009	0.991	0.000
N31.8 Other neuromuscular dysfunction of bladder	0.009	0.991	0.000
R19.0 Intra-abdominal and pelvic swelling, mass and lump	0.009	0.991	0.000
N36.9 Urethral disorder, unspecified	0.009	0.991	0.000
B37.0 Candidal stomatitis	0.009	0.991	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.008	0.991	0.000
N36.3 Prolapsed urethral mucosa	0.008	0.991	0.000
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.008	0.992	0.000
N34.1 Nonspecific urethritis	0.008	0.992	0.000
T45.5 Anticoagulants	0.008	0.992	0.000
T45.4 Iron and its compounds	0.008	0.992	0.000
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.008	0.992	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.008	0.992	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.008	0.992	0.000
T45.8 Other primarily systemic and haematological agents	0.008	0.992	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.008	0.992	0.000
T45.6 Fibrinolysis-affecting drugs	0.008	0.992	0.000
T45.3 Enzymes, not elsewhere classified	0.008	0.992	0.000
T31 Burns classified according to extent of body surface involved	0.000	0.992	0.008
T45.2 Vitamins, not elsewhere classified	0.007	0.992	0.000
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.000	0.993	0.007
T45.0 Antiallergic and antiemetic drugs	0.007	0.993	0.000
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.007	0.993	0.000
B37.1 Pulmonary candidiasis	0.007	0.993	0.000
B37.7 Candidal septicaemia	0.007	0.993	0.000
B37.6 Candidal endocarditis	0.007	0.993	0.000
B37.5 Candidal meningitis	0.007	0.993	0.000
R47 Speech disturbances, not elsewhere classified	0.000	0.993	0.007
B37.4 Candidiasis of other urogenital sites	0.006	0.993	0.000
B37.9 Candidiasis, unspecified	0.006	0.994	0.000
N34.2 Other urethritis	0.006	0.994	0.000
B37.2 Candidiasis of skin and nail	0.006	0.994	0.000
N36.2 Urethral caruncle	0.006	0.994	0.000
N39.9 Disorder of urinary system, unspecified	0.006	0.994	0.000
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)	0.000	0.994	0.006
T31.9 Burns involving 90% or more of body surface	0.000	0.994	0.006
T31.8 Burns involving 80-89% of body surface	0.000	0.994	0.006
T31.7 Burns involving 70-79% of body surface	0.000	0.994	0.006
T31.6 Burns involving 60-69% of body surface	0.000	0.994	0.006
T31.5 Burns involving 50-59% of body surface	0.000	0.994	0.006
T31.4 Burns involving 40-49% of body surface	0.000	0.994	0.006
T31.3 Burns involving 30-39% of body surface	0.000	0.994	0.006
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.006	0.994	0.000
D12.6 Colon, unspecified	0.006	0.994	0.000
R06.5 Mouth breathing	0.006	0.994	0.000
T31.1 Burns involving 10-19% of body surface	0.000	0.994	0.006
N35 Urethral stricture	0.006	0.994	0.000
T31.2 Burns involving 20-29% of body surface	0.000	0.994	0.005
T45.1 Antineoplastic and immunosuppressive drugs	0.005	0.994	0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.006	0.994	0.000
R25.1 Tremor, unspecified	0.000	0.995	0.005
L57 Skin changes due to chronic exposure to nonionising radiation	0.005	0.995	0.000
F31.9 Bipolar affective disorder, unspecified	0.000	0.995	0.005
R47.1 Dysarthria and anarthria	0.000	0.995	0.005
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.005	0.995	0.000
Z57.5 Occupational exposure to toxic agents in other industries	0.005	0.995	0.000
R47.0 Dysphasia and aphasia	0.000	0.995	0.004
N39 Other disorders of urinary system	0.004	0.996	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.004	0.996	0.000
M41.99 Scoliosis, unspecified (Site unspecified)	0.000	0.996	0.004
R06 Abnormalities of breathing	0.004	0.996	0.000
L57.0 Actinic keratosis	0.004	0.996	0.000
R06.0 Dyspnoea	0.004	0.996	0.000
N35.1 Postinfective urethral stricture, not elsewhere classified	0.004	0.996	0.000
R06.2 Wheezing	0.004	0.996	0.000
L57.4 Cutis laxa senilis	0.004	0.996	0.000
M41.9 Scoliosis, unspecified	0.000	0.996	0.004
N35.0 Posttraumatic urethral stricture	0.004	0.996	0.000
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.004	0.996	0.000
R06.1 Stridor	0.004	0.996	0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.000	0.996	0.004
Z43.1 Attention to gastrostomy	0.004	0.996	0.000
E87.2 Acidosis	0.000	0.996	0.004
C85.1 B-cell lymphoma, unspecified	0.000	0.996	0.004
N35.8 Other urethral stricture	0.004	0.996	0.000
L57.5 Actinic granuloma	0.004	0.996	0.000
L57.3 Poikiloderma of Civatte	0.004	0.996	0.000
L57.2 Cutis rhomboidalis nuchae	0.004	0.996	0.000
L57.1 Actinic reticuloid	0.004	0.996	0.000
N32 Other disorders of bladder	0.004	0.996	0.000
T42.0 Hydantoin derivatives	0.004	0.996	0.000
C16.9 Stomach, unspecified	0.004	0.996	0.000
T39.4 Antirheumatics, not elsewhere classified	0.004	0.996	0.000
T39.2 Pyrazolone derivatives	0.004	0.996	0.000
N39.2 Orthostatic proteinuria, unspecified	0.003	0.997	0.000
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M41.94 Scoliosis, unspecified (Thoracic region)	0.000	0.997	0.003
Z43.6 Attention to other artificial openings of urinary tract	0.003	0.997	0.000
M41.92 Scoliosis, unspecified (Cervical region)	0.000	0.997	0.003
T39.0 Salicylates	0.003	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.003	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.997	0.000
R06.7 Sneezing	0.003	0.997	0.000
R06.3 Periodic breathing	0.003	0.997	0.000
N32.3 Diverticulum of bladder	0.003	0.997	0.000
C15.4 Middle third of oesophagus	0.000	0.997	0.003
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.997	0.003
H74.0 Tympanosclerosis	0.000	0.997	0.003
M41.93 Scoliosis, unspecified (Cervicothoracic region)	0.000	0.997	0.003
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)	0.000	0.997	0.003
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.000	0.997	0.003
C83.7 Burkitt's tumour	0.000	0.997	0.003
Z43 Attention to artificial openings	0.003	0.997	0.000
M41.97 Scoliosis, unspecified (Lumbosacral region)	0.000	0.997	0.003
R44.1 Visual hallucinations	0.000	0.997	0.003
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
K51.9 Ulcerative colitis, unspecified	0.003	0.997	0.000
N80.9 Endometriosis, unspecified	0.000	0.997	0.003
C15.9 Oesophagus, unspecified	0.000	0.997	0.003
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
H74 Other disorders of middle ear and mastoid	0.000	0.997	0.003
C83.0 Small cell (diffuse)	0.000	0.997	0.003
Z57 Occupational exposure to risk-factors	0.003	0.997	0.000
M41 Scoliosis	0.000	0.997	0.003
H74.4 Polyp of middle ear	0.000	0.997	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
Z43.5 Attention to cyctostomy	0.003	0.997	0.000
A04.7 Enterocolitis due to Clostridium difficile	0.003	0.997	0.000
N32.4 Rupture of bladder, nontraumatic	0.003	0.997	0.000
H74.3 Other acquired abnormalities of ear ossicles	0.000	0.997	0.003
G81.9 Hemiplegia, unspecified	0.003	0.997	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.997	0.003
C83.1 Small cleaved cell (diffuse)	0.000	0.997	0.003
M25.6 Stiffness of joint, not elsewhere classified	0.000	0.997	0.003
R06.4 Hyperventilation	0.003	0.997	0.000
N32.2 Vesical fistula, not elsewhere classified	0.003	0.997	0.000
M54.39 Sciatica (Site unspecified)	0.003	0.997	0.000
B37.3 Candidiasis of vulva and vagina	0.002	0.997	0.000
Z43.4 Attention to other artificial openings of digestive tract	0.003	0.997	0.000
Z43.0 Attention to tracheostomy	0.003	0.997	0.000
M25.87 Other specified joint disorders (Ankle and foot)	0.003	0.997	0.000
Z57.2 Occupational exposure to dust	0.003	0.997	0.000
H74.1 Adhesive middle ear disease	0.000	0.997	0.003
M41.5 Other secondary scoliosis	0.000	0.997	0.003
R06.6 Hiccough	0.003	0.997	0.000
J98.1 Pulmonary collapse	0.003	0.997	0.000
N39.1 Persistent proteinuria, unspecified	0.003	0.997	0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.000	0.997	0.003
T42.3 Barbiturates	0.002	0.997	0.000
C83.3 Large cell (diffuse)	0.000	0.997	0.003
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.997	0.003
H74.2 Discontinuity and dislocation of ear ossicles	0.000	0.997	0.003
Z53.9 Procedure not carried out, unspecified reason	0.003	0.997	0.000
C83.5 Lymphoblastic (diffuse)	0.000	0.997	0.003
H74.9 Disorder of middle ear and mastoid, unspecified	0.000	0.997	0.003
Z57.8 Occupational exposure to other risk-factors	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
Z43.8 Attention to other artificial openings	0.003	0.997	0.000
C83.6 Undifferentiated (diffuse)	0.000	0.997	0.003
C83.4 Immunoblastic (diffuse)	0.000	0.997	0.003
S40.9 Superficial injury of shoulder and upper arm, unspecified	0.003	0.997	0.000
B35-B49 Mycoses	0.003	0.997	0.000
C92.1 Chronic myeloid leukaemia	0.000	0.997	0.003
C15 Malignant neoplasm of oesophagus	0.000	0.997	0.003
M41.2 Other idiopathic scoliosis	0.000	0.997	0.002
M41.4 Neuromuscular scoliosis	0.000	0.997	0.002
Z43.9 Attention to unspecified artificial opening	0.002	0.997	0.000
Z43.7 Attention to artificial vagina	0.002	0.997	0.000
M25.67 Stiffness of joint, not elsewhere classified (Ankle and foot)	0.000	0.997	0.003
M41.56 Other secondary scoliosis (Lumbar region)	0.000	0.997	0.002
M25.65 Stiffness of joint, not elsewhere classified (Pelvic region and thigh)	0.000	0.997	0.002
C83.2 Mixed small and large cell (diffuse)	0.000	0.997	0.002
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.997	0.003
M41.96 Scoliosis, unspecified (Lumbar region)	0.000	0.997	0.002
Z57.3 Occupational exposure to other air contaminants	0.002	0.997	0.000
Z57.9 Occupational exposure to unspecified risk-factor	0.002	0.997	0.000
Z57.7 Occupational exposure to vibration	0.002	0.997	0.000
Z57.6 Occupational exposure to extreme temperature	0.002	0.997	0.000
Z57.4 Occupational exposure to toxic agents in agriculture	0.002	0.997	0.000
Z57.1 Occupational exposure to radiation	0.002	0.997	0.000
Z57.0 Occupational exposure to noise	0.002	0.997	0.000
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.000	0.997	0.002
M41.3 Thoracogenic scoliosis	0.000	0.997	0.002
M41.1 Juvenile idiopathic scoliosis	0.000	0.997	0.002
M41.0 Infantile idiopathic scoliosis	0.000	0.997	0.002
J92.0 Pleural plaque with presence of asbestos	0.002	0.998	0.000
N32.8 Other specified disorders of bladder	0.002	0.998	0.000
T42.1 Iminostilbenes	0.002	0.998	0.001
M25.64 Stiffness of joint, not elsewhere classified (Hand)	0.000	0.998	0.002
M35.3 Polymyalgia rheumatica	0.002	0.998	0.000
M25.69 Stiffness of joint, not elsewhere classified (Site unspecified)	0.000	0.998	0.002
M41.54 Other secondary scoliosis (Thoracic region)	0.000	0.998	0.002
M25.63 Stiffness of joint, not elsewhere classified (Forearm)	0.000	0.998	0.002
M25.60 Stiffness of joint, not elsewhere classified (Multiple sites)	0.000	0.998	0.002
M40.2 Other and unspecified kyphosis	0.000	0.998	0.002
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.998	0.002
N39.8 Other specified disorders of urinary system	0.002	0.998	0.000
C01 Malignant neoplasm of base of tongue	0.002	0.998	0.000
C92 Myeloid leukaemia	0.000	0.998	0.002
M40 Kyphosis and lordosis	0.000	0.998	0.002
M25.66 Stiffness of joint, not elsewhere classified (Lower leg)	0.000	0.998	0.002
M41.59 Other secondary scoliosis (Site unspecified)	0.000	0.998	0.002
M41.58 Other secondary scoliosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M41.57 Other secondary scoliosis (Lumbosacral region)	0.000	0.998	0.002
M41.55 Other secondary scoliosis (Thoracolumbar region)	0.000	0.998	0.002
M41.53 Other secondary scoliosis (Cervicothoracic region)	0.000	0.998	0.002
M41.52 Other secondary scoliosis (Cervical region)	0.000	0.998	0.002
M41.51 Other secondary scoliosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M41.50 Other secondary scoliosis (Multiple sites in spine)	0.000	0.998	0.002
M41.29 Other idiopathic scoliosis (Site unspecified)	0.000	0.998	0.002
C15.3 Upper third of oesophagus	0.000	0.998	0.002
Z53.2 Procedure not carried out because of patient's decision for other and unspecified reasons	0.002	0.998	0.000
H74.8 Other specified disorders of middle ear and mastoid	0.000	0.998	0.002
M40.24 Other and unspecified kyphosis (Thoracic region)	0.000	0.998	0.002
B49 Unspecified mycosis	0.002	0.998	0.000
M41.49 Neuromuscular scoliosis (Site unspecified)	0.000	0.998	0.002
M25.68 Stiffness of joint, not elsewhere classified (Other)	0.000	0.998	0.002
N32.1 Vesicointestinal fistula	0.002	0.998	0.000
T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system	0.002	0.998	0.000
T30 Burn and corrosion, body region unspecified	0.000	0.998	0.002
C92.9 Myeloid leukaemia, unspecified	0.000	0.998	0.002
B48 Other mycoses, not elsewhere classified	0.002	0.998	0.000
B46 Zygomycosis	0.002	0.998	0.000
B45 Cryptococcosis	0.002	0.998	0.000
B43 Chromomycosis and phaeomycotic abscess	0.002	0.998	0.000
B42 Sporotrichosis	0.002	0.998	0.000
B41 Paracoccidioidomycosis	0.002	0.998	0.000
B40 Blastomycosis	0.002	0.998	0.000
B39 Histoplasmosis	0.002	0.998	0.000
B38 Coccidioidomycosis	0.002	0.998	0.000
M18 Arthrosis of first carpometacarpal joint	0.000	0.998	0.002
T32 Corrosions classified according to extent of body surface involved	0.000	0.998	0.002
B44 Aspergillosis	0.002	0.998	0.000
C15.8 Overlapping lesion of oesophagus	0.000	0.998	0.002
C15.2 Abdominal part of oesophagus	0.000	0.998	0.002
H00.1 Chalazion	0.000	0.998	0.002
B47 Mycetoma	0.002	0.998	0.000
M41.28 Other idiopathic scoliosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M41.27 Other idiopathic scoliosis (Lumbosacral region)	0.000	0.998	0.002
M41.26 Other idiopathic scoliosis (Lumbar region)	0.000	0.998	0.002
M41.25 Other idiopathic scoliosis (Thoracolumbar region)	0.000	0.998	0.002
M41.24 Other idiopathic scoliosis (Thoracic region)	0.000	0.998	0.002
M41.23 Other idiopathic scoliosis (Cervicothoracic region)	0.000	0.998	0.002
M41.22 Other idiopathic scoliosis (Cervical region)	0.000	0.998	0.002
M41.21 Other idiopathic scoliosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M41.20 Other idiopathic scoliosis (Multiple sites in spine)	0.000	0.998	0.002
C15.0 Cervical part of oesophagus	0.000	0.998	0.002
M41.48 Neuromuscular scoliosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M41.47 Neuromuscular scoliosis (Lumbosacral region)	0.000	0.998	0.002
M41.46 Neuromuscular scoliosis (Lumbar region)	0.000	0.998	0.002
M41.45 Neuromuscular scoliosis (Thoracolumbar region)	0.000	0.998	0.002
M41.44 Neuromuscular scoliosis (Thoracic region)	0.000	0.998	0.002
M41.43 Neuromuscular scoliosis (Cervicothoracic region)	0.000	0.998	0.002
M41.42 Neuromuscular scoliosis (Cervical region)	0.000	0.998	0.002
M41.41 Neuromuscular scoliosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M41.40 Neuromuscular scoliosis (Multiple sites in spine)	0.000	0.998	0.002
C15.1 Thoracic part of oesophagus	0.000	0.998	0.002
C81.9 Hodgkin's disease, unspecified	0.000	0.998	0.002
M40.5 Lordosis, unspecified	0.000	0.998	0.002
T29 Burns and corrosions of multiple body regions	0.000	0.998	0.002
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.002	0.998	0.000
M25.62 Stiffness of joint, not elsewhere classified (Upper arm)	0.000	0.998	0.002
M41.8 Other forms of scoliosis	0.000	0.998	0.002
Z88.5 Personal history of allergy to narcotic agent	0.000	0.998	0.002
C81 Hodgkin's disease	0.000	0.998	0.002
G81 Hemiplegia	0.002	0.998	0.000
M41.09 Infantile idiopathic scoliosis (Site unspecified)	0.000	0.998	0.002
M41.08 Infantile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M41.07 Infantile idiopathic scoliosis (Lumbosacral region)	0.000	0.998	0.002
M41.06 Infantile idiopathic scoliosis (Lumbar region)	0.000	0.998	0.002
M41.05 Infantile idiopathic scoliosis (Thoracolumbar region)	0.000	0.998	0.002
M41.04 Infantile idiopathic scoliosis (Thoracic region)	0.000	0.998	0.002
M41.03 Infantile idiopathic scoliosis (Cervicothoracic region)	0.000	0.998	0.002
M41.02 Infantile idiopathic scoliosis (Cervical region)	0.000	0.998	0.002
M41.01 Infantile idiopathic scoliosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M41.00 Infantile idiopathic scoliosis (Multiple sites in spine)	0.000	0.998	0.002
M41.19 Juvenile idiopathic scoliosis (Site unspecified)	0.000	0.998	0.002
M41.18 Juvenile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M41.17 Juvenile idiopathic scoliosis (Lumbosacral region)	0.000	0.998	0.002
M41.16 Juvenile idiopathic scoliosis (Lumbar region)	0.000	0.998	0.002
M41.15 Juvenile idiopathic scoliosis (Thoracolumbar region)	0.000	0.998	0.002
M41.14 Juvenile idiopathic scoliosis (Thoracic region)	0.000	0.998	0.002
M41.13 Juvenile idiopathic scoliosis (Cervicothoracic region)	0.000	0.998	0.002
M41.12 Juvenile idiopathic scoliosis (Cervical region)	0.000	0.998	0.002
M41.11 Juvenile idiopathic scoliosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M41.10 Juvenile idiopathic scoliosis (Multiple sites in spine)	0.000	0.998	0.002
M41.39 Thoracogenic scoliosis-Site unspe	0.000	0.998	0.002
M41.38 Thoracogenic scoliosis-Sacral/sacrococ	0.000	0.998	0.002
M41.37 Thoracogenic scoliosis-Lumbosacral	0.000	0.998	0.002
M41.36 Thoracogenic scoliosis-Lumbar	0.000	0.998	0.002
M41.35 Thoracogenic scoliosis (Thoracolumbar region)	0.000	0.998	0.002
M41.34 Thoracogenic scoliosis (Thoracic region)	0.000	0.998	0.002
M41.33 Thoracogenic scoliosis (Cervicothoracic region)	0.000	0.998	0.002
M41.32 Thoracogenic scoliosis-Cervical	0.000	0.998	0.002
M41.31 Thoracogenic scoliosis-Occipit-atl-axl	0.000	0.998	0.002
M41.30 Thoracogenic scoliosis (Multiple sites in spine)	0.000	0.998	0.002
C16.0 Cardia	0.002	0.998	0.000
M40-M43 Deforming dorsopathies	0.000	0.998	0.002
M40.25 Other and unspecified kyphosis (Thoracolumbar region)	0.000	0.998	0.002
B36 Other superficial mycoses	0.002	0.998	0.000
C91 Lymphoid leukaemia	0.000	0.998	0.002
C91.0 Acute lymphoblastic leukaemia	0.000	0.998	0.002
O62.3 Precipitate labour	0.000	0.998	0.002
I10-I15 Hypertensive diseases	0.002	0.998	0.000
M40.56 Lordosis, unspecified (Lumbar region)	0.000	0.998	0.002
C85.0 Lymphosarcoma	0.000	0.998	0.002
Z49.0 Preparatory care for dialysis	0.002	0.998	0.000
C95 Leukaemia of unspecified cell type	0.000	0.998	0.002
H52.3 Anisometropia and aniseikonia	0.002	0.998	0.000
M40.1 Other secondary kyphosis	0.000	0.998	0.002
C88 Malignant immunoproliferative diseases	0.000	0.998	0.002
M40.29 Other and unspecified kyphosis (Site unspecified)	0.000	0.998	0.002
M40.22 Other and unspecified kyphosis (Cervical region)	0.000	0.998	0.002
T42.4 Benzodiazepines	0.002	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.000	0.998	0.002
Z85.9 Personal history of malignant neoplasm, unspecified	0.000	0.998	0.002
M40.28 Other and unspecified kyphosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M40.27 Other and unspecified kyphosis (Lumbosacral region)	0.000	0.998	0.002
M40.23 Other and unspecified kyphosis (Cervicothoracic region)	0.000	0.998	0.002
M40.21 Other and unspecified kyphosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M40.20 Other and unspecified kyphosis (Multiple sites in spine)	0.000	0.998	0.002
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.998	0.002
C92.4 Acute promyelocytic leukaemia	0.000	0.998	0.002
G81.1 Spastic hemiplegia	0.002	0.998	0.000
Z43.2 Attention to ileostomy	0.002	0.998	0.000
Z99.2 Dependence on renal dialysis	0.002	0.998	0.000
C16 Malignant neoplasm of stomach	0.002	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.998	0.002
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.998	0.002
C92.3 Myeloid sarcoma	0.000	0.998	0.002
C92.2 Subacute myeloid leukaemia	0.000	0.998	0.002
M40.4 Other lordosis	0.000	0.998	0.002
M40.3 Flatback syndrome	0.000	0.998	0.002
M40.0 Postural kyphosis	0.000	0.998	0.002
R44.8 Other and unspecified symptoms and signs involving general sensations and perceptions	0.000	0.998	0.002
T23.2 Burn of second degree of wrist and hand	0.000	0.998	0.002
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.998	0.002
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.002	0.998	0.000
C15.5 Lower third of oesophagus	0.000	0.998	0.002
M40.26 Other and unspecified kyphosis (Lumbar region)	0.000	0.998	0.002
K76.9 Liver disease, unspecified	0.000	0.998	0.002
C94 Other leukaemias of specified cell type	0.000	0.998	0.002
M25.53 Pain in joint (Forearm)	0.000	0.998	0.002
B44.8 Other forms of aspergillosis	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations